Clinical trials
Phase 1 Alzheimer Disease trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerecin | 4 |
| GlaxoSmithKline | 3 |
| Alector Inc. | 2 |
| Atridia Pty Ltd. | 2 |
| Acta Pharmaceuticals | 1 |
| Asceneuron Pty Ltd. | 1 |
| Avid Radiopharmaceuticals | 1 |
| Cognition Therapeutics | 1 |
| Eli Lilly and Company | 1 |
| Inmune Bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 26 |
| Cognitive Dysfunction | 3 |
| Neurodegenerative Diseases | 2 |
| Dementia | 1 |
| Inflammation | 1 |
| Plaque, Amyloid | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.